Last update 23 Jan 2025

Changkang Granules

Overview

Basic Info

Drug Type
Herbal medicine
Synonyms
Target-
Mechanism-
Therapeutic Areas
Digestive System Disorders
Active Indication
Irritable bowel syndrome with diarrhea
Inactive Indication-
Originator Organization
Tasly Pharmaceutical Group Co., Ltd.Tasly Pharmaceutical Group Co., Ltd.
Active Organization
Tasly Pharmaceutical Group Co., Ltd.Tasly Pharmaceutical Group Co., Ltd.Jiangsu Province Hospital of Traditional Chinese MedicineJiangsu Province Hospital of Traditional Chinese Medicine
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Changkang Granules
CTR20244249
/ Not yet recruitingPhase 3
肠康颗粒治疗腹泻型肠易激综合征（肝气乘脾证）有效性和安全性的多中心、随机、双盲、安慰剂对照Ⅲ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial on the efficacy and safety of Changkang granules in the treatment of diarrhea-predominant irritable bowel syndrome (liver qi invading spleen syndrome)
NCT06753890
/ Not yet recruitingPhase 3
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical Trial, Efficacy and Safety Study of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea ( Liver qi Affecting the Spleen Pattern)
CTR20200075
/ CompletedPhase 2
肠康颗粒治疗腹泻型肠易激综合征有效性和安全性的多中心、随机、双盲、安慰剂对照Ⅱ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial on the efficacy and safety of Changkang granules in the treatment of diarrhea-predominant irritable bowel syndrome
100 Clinical Results associated with Changkang Granules
Login to view more data
100 Translational Medicine associated with Changkang Granules
Login to view more data
100 Patents (Medical) associated with Changkang Granules
Login to view more data
100 Deals associated with Changkang Granules
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Irritable bowel syndrome with diarrheaPhase 3
CN
Tasly Pharmaceutical Group Co., Ltd.Tasly Pharmaceutical Group Co., Ltd.
27 Nov 2024
Irritable bowel syndrome with diarrheaPhase 3
CN
Jiangsu Province Hospital of Traditional Chinese MedicineJiangsu Province Hospital of Traditional Chinese Medicine
27 Nov 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free